MedPath

Predictive Value of Serum Uric Acid to HDL Cholesterol Ratio for Diabetic Kidney Injury in Type 2 Diabetes

Not yet recruiting
Conditions
Diabetic Kidney Injury
Interventions
Diagnostic Test: serum uric acid level to plasma HDL-c level ratio (UHR)
Registration Number
NCT06349850
Lead Sponsor
Sohag University
Brief Summary

An prospective observetional study to asses the predictive value of serum uric acid to high density lipoprotein cholesterol ratio for diabetic kidney injury in type 2 diabetes

Detailed Description

Diabetic Kidney Injury (DKI) is a serious microvascular complication of diabetes mellitus occuring in about 20 % to 50% of diabetic patients and is the single commonest cause of ESRD.DKI is asociated with arterial HTN and increased cardiovascular morbidity and mortality. outcomes for both type 1 DM and type 2 DM who develop DKI are significantly worse than who do not .Serum uric acid was reported to be asociated with inflamatory and metabolic diseases such as metabolic syndrome , type 2 DM,thyroiditis and NAFLD while HDL-cholesterol decreased the odds of developing DKI by 20%.It is generally accepted that hyperuricemia and low HDL-c were considered to be a risk factor of other indicators for development of DKI.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
100
Inclusion Criteria
  • Type 2 diabetic patients
  • willing and agreed to be included in the study
Exclusion Criteria
  • Type 1 DM patients
  • patients with active urinary sediment
  • patients with glomerulonephritis
  • patients with diagnosis or clinical features that are suspicious for another systemic disease that commonly causes kidney disease
  • patients with evidence of alternative kidney disease
  • patients with history of kidney transplantation
  • patients with end stage renal disease
  • patients with family history of non diabetic forms of kidney disease
  • patients with active malignancy
  • patients with established hemolytic disease
  • CKD patients requiring dialysis
  • patients taking drugs that interfere with serum uric acid level
  • patients taking drugs that alter serum lipids level
  • pregnancy
  • Refused to consent to this study

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
UHR level groupserum uric acid level to plasma HDL-c level ratio (UHR)median levels of UHR will be used to dichotomize the patients into groups of : * low UHR group * high UHR group
DKI groupserum uric acid level to plasma HDL-c level ratio (UHR)study population will be grouped into another two groups according to the presence of DKI: * patients with DKI * patients without DKI
HbA1c level groupserum uric acid level to plasma HDL-c level ratio (UHR)* well controlled diabetic group : HBA1c less than 7% * poorly controlled diabetic group : HBA1c equal to ore more than 7%
Primary Outcome Measures
NameTimeMethod
Uric acid to HDL-c ratio (UHR)6 months

asociation of high UHR with development of DKI in type 2 DM

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath